Jain, Bhav
Bajaj, Simar Singh
Patel, Tej A.
Vapiwala, Neha
Lam, Miranda B.
Mahal, Brandon A.
Muralidhar, Vinayak
Amen, Troy B.
Nguyen, Paul L.
Sanford, Nina N.
Dee, Edward Christopher http://orcid.org/0000-0001-6119-0889
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (R01-CA240582)
Article History
Received: 10 April 2023
Accepted: 12 April 2023
First Online: 29 April 2023
Disclosures
: V.M. is employed by Northwest Permanente. B.A.M. receives funding from the Prostate Cancer Foundation (PCF), the American Society for Radiation Oncology (ASTRO), the Department of Defense, and the Sylvester Comprehensive Cancer Center outside the submitted work. P.L.N. reported receiving research funding from Astellas, Bayer, and Janssen; P.L.N. has consulted for Novartis, Bayer, Janssen, Nanocan, Boston Scientific, and AIQ; P.L.N. reports equity in Nanocan and Stratagen Bio.